Reglagene
Tucson
About Reglagene
Reglagene mainly engages in transforming tubulin therapy for brain diseases. It leverages its expertise in the design and development of brain-penetrant medicines to create breakthrough therapies for the safe and effective treatment of brain diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.3M
- Last round: Series Unknown (May 2024)
- Website: reglagene.com
- Phone: (520) 235-0365
Industries & Categories
Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/reglagene-156633 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.